Stage III Non Small Cell Lung Cancer research hub

IFCT-2501 IDEATION ctDNA-guIDEd consolidATION immunotherapy after chemoradiotherapy in patients with stage III non-small cell lung cancer

This study looks at an immunotherapy medicine called Imfinzi for people with stage 3 non-small cell lung cancer. It explores whether using special blood tests to look for tiny traces of tumour DNA can help doctors guide treatment after chemoradiotherapy, aiming to stop the cancer from returning.